ACOG 2011)
Retatrutide is often described as 8.9 times native GIP potency, 0.40 times native GLP-1 potency, and 0.34 times native glucagon potency
However, frequent unpredictable timing confuses your appetite regulation system and makes it harder to distinguish whether nausea or inadequate appetite suppression stems from dose level, timing inconsistency, or medication tolerance
Secondly, a review of clinical trials presented at ENDO 2026 which is yet to appear in a peer-reviewed journal found that GLP-1 drugs may improve testosterone levels and sperm quality in some men with obesity
In March 2025, Stanford Medicine researchers used artificial intelligence to identify a naturally occurring peptide (BRP) that reduced food intake and body weight in animal models working through a separate metabolic pathway from existing GLP-1 drugs and without producing the nausea commonly associated with them
In the meantime, visit our blog to learn more about additional procedures and how we help to improve our patients lives
